VYGR

Voyager Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · VYGR

All alert types
1.72 USD -0.04 -2.27%
As of Oct 30, 2026 Extended hours 1.73 +0.58%
Bid
1.71 × 2
Ask
1.72 × 2
1.68 Day range 1.76
1.72 52-week range 5.00
YTD
-56.23%
1 year
-61.95%
Open
1.75
Prev close
1.76
Mkt cap
105.98M
Vol
878.83K
Avg vol
654.75K
EPS
-1.81
P/E
0.00
Div yield
0.00%
More statistics
Low
1.68
High
1.76
Forward P/E
-3.41
Beta
0.89
Short ratio
4.44
Inst. own
65.52%
Dividend
0.00
Ex-div date
50-d avg
6.52
200-d avg
7.56
1y target
17.10

5D chart

Chart tools
Interval
VYGR five-day price chart1.671.731.781.841.90Oct 26Oct 27Oct 29Oct 30

Financial health

Altman Z-Score

-3.02 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 4

Valuation

P/E -1.9×
FY 2016: -8.0×FY 2017: -6.3×FY 2018: -3.4×FY 2019: -12.2×FY 2020: 7.2×FY 2021: -1.5×FY 2022: -5.0×FY 2023: 2.7×FY 2024: -5.0×FY 2025: -1.9×
FY 2016 5y median -1.9× FY 2025
P/S 5.7×
FY 2016: 22.7×FY 2017: 43.9×FY 2018: 39.6×FY 2019: 4.8×FY 2020: 1.6×FY 2021: 2.7×FY 2022: 5.7×FY 2023: 1.5×FY 2024: 4.1×FY 2025: 5.7×
FY 2016 5y median 4.1× FY 2025
P/B 1.2×
FY 2016: 2.4×FY 2017: 3.3×FY 2018: 6.5×FY 2019: 5.0×FY 2020: 1.7×FY 2021: 1.1×FY 2022: 4.0×FY 2023: 1.5×FY 2024: 1.1×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
P/FCF -1.7×
FY 2016: -6.8×FY 2017: -6.8×FY 2018: -14.9×FY 2019: 12.2×FY 2020: -2.4×FY 2021: -1.9×FY 2022: -15.6×FY 2023: 4.9×FY 2024: -17.4×FY 2025: -1.7×
FY 2016 5y median -1.9× FY 2025
EV/EBITDA -1.7×
FY 2016: -7.0×FY 2017: -5.9×FY 2018: -2.9×FY 2019: -9.2×FY 2020: 6.7×FY 2021: -0.4×FY 2022: -4.0×FY 2023: 2.3×FY 2024: -5.0×FY 2025: -1.7×
FY 2016 5y median -1.7× FY 2025
EV/Sales 5.0×
FY 2016: 20.1×FY 2017: 40.8×FY 2018: 33.4×FY 2019: 4.3×FY 2020: 1.2×FY 2021: 0.8×FY 2022: 3.9×FY 2023: 1.3×FY 2024: 3.7×FY 2025: 5.0×
FY 2016 5y median 3.7× FY 2025
FCF Yield -58.6%
FY 2016: -14.7%FY 2017: -14.7%FY 2018: -6.7%FY 2019: 8.2%FY 2020: -41.0%FY 2021: -54.0%FY 2022: -6.4%FY 2023: 20.6%FY 2024: -5.8%FY 2025: -58.6%
FY 2016 5y median -6.4% FY 2025

Profitability

Gross Margin -227.6%
FY 2016: -197.1%FY 2017: -514.3%FY 2018: -751.9%FY 2019: -14.7%FY 2020: 36.4%FY 2021: -97.2%FY 2022: -36.3%FY 2023: 63.1%FY 2024: 100.0%FY 2025: -227.6%
FY 2016 5y median -36.3% FY 2025
Operating Margin -326.6%
FY 2016: -290.4%FY 2017: -709.1%FY 2018: -1195.6%FY 2019: -49.5%FY 2020: 16.0%FY 2021: -196.8%FY 2022: -124.3%FY 2023: 48.8%FY 2024: -104.1%FY 2025: -326.6%
FY 2016 5y median -124.3% FY 2025
Net Margin -296.5%
FY 2016: -282.7%FY 2017: -697.6%FY 2018: -1158.8%FY 2019: -41.8%FY 2020: 21.5%FY 2021: -190.3%FY 2022: -113.4%FY 2023: 52.9%FY 2024: -81.3%FY 2025: -296.5%
FY 2016 5y median -113.4% FY 2025
ROE -61.1%
FY 2016: -29.6%FY 2017: -52.7%FY 2018: -190.1%FY 2019: -43.8%FY 2020: 23.8%FY 2021: -74.9%FY 2022: -78.6%FY 2023: 56.0%FY 2024: -21.7%FY 2025: -61.1%
FY 2016 5y median -61.1% FY 2025
ROIC -56.4%
FY 2016: -23.5%FY 2017: -42.6%FY 2018: -62.5%FY 2019: -18.3%FY 2020: 11.5%FY 2021: -49.6%FY 2022: -56.7%FY 2023: 41.6%FY 2024: -23.8%FY 2025: -56.4%
FY 2016 5y median -49.6% FY 2025
ROA -47.5%
FY 2016: -21.2%FY 2017: -38.3%FY 2018: -49.9%FY 2019: -12.3%FY 2020: 14.0%FY 2021: -36.7%FY 2022: -29.1%FY 2023: 37.7%FY 2024: -16.5%FY 2025: -47.5%
FY 2016 5y median -29.1% FY 2025

Growth (YoY)

Revenue -49.5%
FY 2016: -18.0%FY 2017: -28.7%FY 2018: -24.8%FY 2019: 1270.1%FY 2020: 63.9%FY 2021: -78.1%FY 2022: 9.3%FY 2023: 511.2%FY 2024: -68.0%FY 2025: -49.5%
FY 2016 FY 2025
Operating Income -58.3%
FY 2016: -103.9%FY 2017: -74.0%FY 2018: -26.8%FY 2019: 43.3%FY 2020: 153.0%FY 2021: -368.8%FY 2022: 30.9%FY 2023: 340.0%FY 2024: -168.3%FY 2025: -58.3%
FY 2016 FY 2025
EPS (diluted) -80.5%
FY 2016: 77.5%FY 2017: -66.0%FY 2018: -4.2%FY 2019: 58.5%FY 2020: 186.0%FY 2021: -278.6%FY 2022: 30.9%FY 2023: 345.5%FY 2024: -138.0%FY 2025: -80.5%
FY 2016 FY 2025
Free Cash Flow -617.2%
FY 2016: -218.0%FY 2017: -37.5%FY 2018: 69.1%FY 2019: 302.8%FY 2020: -365.7%FY 2021: 49.3%FY 2022: 72.8%FY 2023: 597.8%FY 2024: -125.2%FY 2025: -617.2%
FY 2016 FY 2025

Financial Health

Current Ratio 7.6×
FY 2016: 13.0×FY 2017: 10.8×FY 2018: 5.1×FY 2019: 4.0×FY 2020: 7.4×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 5.0×FY 2024: 5.6×FY 2025: 7.6×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 7.6×
FY 2016: 12.8×FY 2017: 10.7×FY 2018: 5.0×FY 2019: 4.0×FY 2020: 7.4×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 5.0×FY 2024: 5.6×FY 2025: 7.6×
FY 2016 5y median 5.0× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.5×FY 2022: 0.4×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.9×FY 2017: 0.4×FY 2018: 0.5×FY 2019: 1.1×FY 2020: -1.8×FY 2021: 1.1×FY 2022: 1.9×FY 2023: -0.4×FY 2024: 0.5×FY 2025: 0.2×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: -42.3×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31